The healthcare burden of hypertension in Asia
- 1 January 2013
- journal article
- Published by BMJ in Heart Asia
- Vol. 5 (1) , 238-243
Abstract
As the leading global risk for mortality, hypertension (HT) is a common healthcare problem in the world. The total number of patients with HT is likely to grow in the next few decades as the population age and the prevalence of obesity and diabetes increase. HT, as a major modifiable risk factor for cardiovascular disease, results in more deaths than any other risk factors, including diabetes and cigarette smoking. High prevalence, inadequate awareness, suboptimal treatment and low rate of achieving guideline-recommended target blood pressure control are key factors leading to severe cardiovascular complications that impose a heavy socioeconomic burden, especially in developing countries. Asia is the world's largest and most populous continent with approximately 4.3 billion people, hosting 60% of the world’s current human population, and has a high growth rate. Asia differs very widely from the West with regard to ethnic groups, cultures, environments, economics, historical ties and government systems. Therefore, the purpose of this review is to comprehensively summarise the epidemiology, treatment practice and the status of control of HT in different Asian countries in order to guide the future prevention and management in this part of the world.Keywords
This publication has 65 references indexed in Scilit:
- Incidence and Prognosis of Resistant Hypertension in Hypertensive PatientsCirculation, 2012
- Hypertension in children and adolescents: epidemiology and natural historyPediatric Nephrology, 2009
- Prevalence, Awareness, Treatment, and Control of Hypertension in ChinaCirculation, 2008
- Association Between Raised Blood Pressure and Dysglycemia in Hong Kong ChineseDiabetes Care, 2008
- The Optimal Target Blood Pressure for Antihypertensive Treatment in Japanese Elderly Patients with High-Risk Hypertension: A Subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) TrialHypertension Research, 2008
- RETRACTED: Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality studyThe Lancet, 2007
- Dietary Approaches to Prevent and Treat HypertensionHypertension, 2006
- Global burden of hypertension: analysis of worldwide dataThe Lancet, 2005
- Trends in Blood Pressure Among Children and AdolescentsJAMA, 2004
- Trends and social factors in blood pressure control in Scottish MONICA surveys 1986–1995: the rule of halves revisitedJournal of Human Hypertension, 2003